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Uwill Discover Abstract 
Towards the Synthesis of a C-glycoside Serine Tn Antigen  
Thomson Ly, Advait Desai, Iraj Sadraei, John F. Trant 
Many biological processes including bacterial and viral infections (notably HIV and the flu), immunogenic 
responses, and cancer pathogenesis/metastasis are mediated by carbohydrate interactions. An example 
of such a carbohydrate is the Tn antigen. The Tn antigen is particularly interesting as it shows up in a 
large number of different cancer cells including: gastric, colon, breast, lung, esophageal, prostate, and 
endometrial cancer. If the immune system could be trained to target this molecule, then the immune 
system could be used to help cure cancer. A key drawback to using this method is the inherent low in 
vivo half-lives of carbohydrate containing materials. This Trant Team project aims to remove the 
unstable acetal functionality of the Tn antigen by replacing the exocyclic anomeric oxygen with a 
methylene (C-glycoside) to make new acetal-free C-glycoside analogues of the Tn antigen. Removing the 
labile functionality should result in greatly enhanced lifetime, and bioavailability relative to the native 
system with no loss of activity as the exocyclic oxygen is not involved in the vast majority of molecular 
recognition events. This molecule is being made by total synthesis for its incorporation into new anti-
cancer vaccines. 
 
